Replies to post #629 on Horizon Therapeutics Public Limited Co (fka HZNP)

[Investor100]

Horizon Pharma (HZNP) Stock Gains on Raised Guidance

NEW YORK (TheStreet) -- Horizon Pharma (HZNP - Get Report) stock is up by 6.14% to $19.20 in mid-morning trading on Tuesday, after the company raised its full-year 2016 revenue guidance.

The Irish biopharmaceutical company announced on Tuesday that it expects full-year revenue of $1.03 to $1.05 billion, versus its previous projection for revenue between $950 million and $975 million for the year.

Horizon raised its revenue guidance as its acquisition of Crealta Holdings is expected to close this week, the company said in a statement.

http://www.thestreet.com/story/13421121/1/horizon-pharma-hznp-stock-gains-on-raised-guidance.html?puc=yahoo&cm_ven=YAHOO

Investor 100